<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03087084</url>
  </required_header>
  <id_info>
    <org_study_id>REST-HF</org_study_id>
    <nct_id>NCT03087084</nct_id>
  </id_info>
  <brief_title>RESpiration deTection From Implanted Cardiac Devices in Subjects With Heart Failure (REST-HF)</brief_title>
  <acronym>REST-HF</acronym>
  <official_title>RESpiration deTection From Implanted Cardiac Devices in Subjects With Heart Failure (REST-HF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic BRC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic BRC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective, non-randomized, single-arm, research study is to evaluate
      the accuracy of acutely extracting respiratory rate and tidal volume from implanted cardiac
      device impedance in subjects with heart failure.

      In addition, to assess the feasibility of extracting respiratory rate from device EGM under
      various conditions.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 7, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of extracting respiratory features from intrathoracic impedance acutely in subjects with heart failure</measure>
    <time_frame>Implant</time_frame>
    <description>Impedance-derived respiratory rate during different breathing patterns</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the feasibility of extracting respiratory rate from EGM under various conditions</measure>
    <time_frame>Implant and 2 months follow-up</time_frame>
    <description>EGM derived respiratory rate under various conditions.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Cardiac Pacing and Impedance Measurement system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac Pacing and Impedance Measurement system</intervention_name>
    <description>Subjects indicated for Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Defibrillator device implant will be requested to perform some respiratory manoeuvres while impedance and electrogram signals are recorded by the system</description>
    <arm_group_label>Cardiac Pacing and Impedance Measurement system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must have heart failure and be undergoing implant of a new or
             replacement/upgrade Medtronic dual-chamber Implantable Cardioverter Defibrillator or
             Cardiac Resynchronization Therapy Defibrillator device for approved indications;

          -  Subject must be implanted with an right ventricle lead that supports bipolar pacing
             and sensing (i.e. a true bipolar defibrillation lead);

          -  Subject must receive a light conscious sedation or no sedation where breathing
             maneuvers can be performed and evaluated during the implant;

          -  Subject must be willing to provide Informed Consent for their participation in the
             study;

          -  Subject must be â‰¥ 18 years of age.

        Exclusion Criteria:

          -  Subjects who are unable or unwilling to voluntarily participate in any visit required
             by the study and to provide consent;

          -  Subject has congenital heart disease;

          -  Subject has a tachyarrhythmia (atrial and/or ventricular) at the time of enrollment
             and a cardioversion will not be attempted prior to the research procedure;

          -  Subject has unstable coronary artery disease;

          -  Subject requires cardiac pacing at rest for rate support;

          -  Subject presents any concomitant conditions which in the opinion of the investigator
             would not allow a proper execution of the respiratory exercises as per protocol;

          -  Subject presents any concomitant condition which in the opinion of the investigator
             would not allow a safe participation in the study;

          -  Subject is pregnant or breast feeding;

          -  Subject is legally incompetent;

          -  Subject is enrolled in a concurrent study that may confound the results of this study
             without documented pre-approval from Medtronic study manager.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederic Van Heuverswyn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Gent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ashley Chin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groote Schuur Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hielko Miljoen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Antwerp</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rogier Receveur, Ir</last_name>
    <phone>+31-43-35-66-566</phone>
    <email>rogier.receveur@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dafni Carmina, Ir</last_name>
    <email>dafni.carmina@medtronic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Antwerpen</name>
      <address>
        <city>Antwerpen</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hielko Miljoen, MD</last_name>
      <email>Hielko.Miljoen@uza.be</email>
    </contact>
    <investigator>
      <last_name>Hielko Miljoen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic Van Heuverswyn, MD</last_name>
      <email>frederic.vanheuverswyn@uzgent.be</email>
    </contact>
    <investigator>
      <last_name>Frederic MD Van Heuverswyn</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groote Schuur Hospital</name>
      <address>
        <city>Cape Town</city>
        <zip>7925</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Chin, MD</last_name>
      <email>ashley.chin@uct.ac.za</email>
    </contact>
    <investigator>
      <last_name>Ashley Chin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>South Africa</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 17, 2017</study_first_submitted>
  <study_first_submitted_qc>March 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <last_update_submitted>February 22, 2019</last_update_submitted>
  <last_update_submitted_qc>February 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

